Skip to main content
Erschienen in: Lung 3/2016

15.03.2016

Complications and Yield of Computed Tomography-Guided Transthoracic Core Needle Biopsy of Lung Nodules at a High-Volume Academic Center in an Endemic Coccidioidomycosis Area

verfasst von: Mickey Sachdeva, Reza Ronaghi, Paul K. Mills, Michael W. Peterson

Erschienen in: Lung | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previous studies with small sample sizes have shown a wide range of complication rates and no study has investigated the yield of computed tomography-guided transthoracic core needle biopsies (CTTCB) for coccidioidomycosis. To better assess the safety, accuracy, and risk factors for complications of CTTCB of pulmonary nodules, we conducted a retrospective study at a high-volume academic center in an endemic coccidioidomycosis area.

Methods

We conducted a retrospective study of 203 patients who underwent CTTCB of pulmonary nodules between December 2010 and May 2013. We collected demographics, clinical, and radiographic data. Each case was reviewed for complications. Diagnostic accuracy was assessed by comparing CTTCB with final diagnoses.

Results

The overall complication rate was 25 %. Pneumothorax accounted for 24 % of complications with 7 % of pneumothoraces requiring chest tube. 1.5 % were complicated by hemoptysis but none required blood transfusions. There was an association between complications and age, presence of emphysema on CT, traversed lung length, and lesion depth. The overall sensitivity of the CTTCB for all types of lung cancer was 93 %, and specificity of 100 %. The positive predictive value of CTTCB for lung cancer was 100 %. The sensitivity and specificity of CTTCB for a coccidiomycosis lung nodule was 83 % with a specificity of 100 % with a PPV of 100 %.

Conclusion

Our study demonstrates that CTTCB is a relatively safe method for evaluating lung nodules and highly accurate in evaluating lung nodules due to coccidioidomycosis in an endemic area. The primary risk factors for complications from CTTCB are the presence of emphysema on CT scan, lesion depth, and traversed lung length.
Literatur
1.
Zurück zum Zitat Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5Suppl):e93S–e120SCrossRefPubMedPubMedCentral Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5Suppl):e93S–e120SCrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Croft DR, Trapp J, Kernstine K et al (2002) FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 36(3):297–301CrossRefPubMed Croft DR, Trapp J, Kernstine K et al (2002) FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 36(3):297–301CrossRefPubMed
3.
Zurück zum Zitat Reyes N, Onadeko OO, Luraschi-Monjagatta MD et al (2014) Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 192(4):589–593CrossRefPubMed Reyes N, Onadeko OO, Luraschi-Monjagatta MD et al (2014) Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 192(4):589–593CrossRefPubMed
4.
Zurück zum Zitat Khan MF, Straub R, Moghaddam SR et al (2008) Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol 18(7):1356–1363CrossRefPubMed Khan MF, Straub R, Moghaddam SR et al (2008) Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol 18(7):1356–1363CrossRefPubMed
6.
Zurück zum Zitat Forseth J, Rohwedder JJ, Levine BE et al (1986) Experience with needle biopsy for coccidioidal lung nodules. Arch Intern Med 146(2):319–320CrossRefPubMed Forseth J, Rohwedder JJ, Levine BE et al (1986) Experience with needle biopsy for coccidioidal lung nodules. Arch Intern Med 146(2):319–320CrossRefPubMed
7.
Zurück zum Zitat Loubeyre P, Copercini M, Dietrich PY (2005) Percutaneous CT-guided multisampling core needle biopsy of thoracic lesions. Am J Roentgenol 185(5):1294–1298CrossRef Loubeyre P, Copercini M, Dietrich PY (2005) Percutaneous CT-guided multisampling core needle biopsy of thoracic lesions. Am J Roentgenol 185(5):1294–1298CrossRef
8.
Zurück zum Zitat Wiener RS, Schwartz LM, Woloshin S et al (2011) Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med 155(3):137–144CrossRefPubMedPubMedCentral Wiener RS, Schwartz LM, Woloshin S et al (2011) Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med 155(3):137–144CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Montaudon M, Latrabe V, Pariente A et al (2004) Factors influencing accuracy of CT-guided percutaneous biopsies of pulmonary lesions. Eur Radiol 14(7):1234–1240 Epub 2004 Feb 13 CrossRefPubMed Montaudon M, Latrabe V, Pariente A et al (2004) Factors influencing accuracy of CT-guided percutaneous biopsies of pulmonary lesions. Eur Radiol 14(7):1234–1240 Epub 2004 Feb 13 CrossRefPubMed
10.
Zurück zum Zitat Heyer CM, Reichelt S, Peters SA et al (2008) Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates? Acad Radiol. 15(8):1017–1026CrossRefPubMed Heyer CM, Reichelt S, Peters SA et al (2008) Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates? Acad Radiol. 15(8):1017–1026CrossRefPubMed
11.
Zurück zum Zitat Yeow KM, Su IH, Pan KT et al (2004) Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 126(3):748–754CrossRefPubMed Yeow KM, Su IH, Pan KT et al (2004) Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 126(3):748–754CrossRefPubMed
12.
Zurück zum Zitat Li Y, Du Y, Yang HF et al (2013) CT-guided percutaneous core needle biopsy for small (≤20 mm) pulmonary lesions. Clin Radiol 68(1):e43–e48CrossRefPubMed Li Y, Du Y, Yang HF et al (2013) CT-guided percutaneous core needle biopsy for small (≤20 mm) pulmonary lesions. Clin Radiol 68(1):e43–e48CrossRefPubMed
13.
Zurück zum Zitat Covey AM, Gandhi R, Brody LA et al (2004) Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol 15(5):479–483CrossRefPubMed Covey AM, Gandhi R, Brody LA et al (2004) Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol 15(5):479–483CrossRefPubMed
14.
Zurück zum Zitat Chakrabarti B, Earis JE, Pandey R et al (2009) Risk assessment of pneumothorax and pulmonary haemorrhage complicating percutaneous co axial cutting needle lung biopsy. Respir Med 103(3):449–455CrossRefPubMed Chakrabarti B, Earis JE, Pandey R et al (2009) Risk assessment of pneumothorax and pulmonary haemorrhage complicating percutaneous co axial cutting needle lung biopsy. Respir Med 103(3):449–455CrossRefPubMed
15.
Zurück zum Zitat Yildirim E, Kirbas I, Harman A et al (2009) CT-guided cutting needle lung biopsy using modified coaxial technique: factors effecting risk of complications. Eur J Radiol 70(1):57–60CrossRefPubMed Yildirim E, Kirbas I, Harman A et al (2009) CT-guided cutting needle lung biopsy using modified coaxial technique: factors effecting risk of complications. Eur J Radiol 70(1):57–60CrossRefPubMed
16.
Zurück zum Zitat Saji H, Nakamura H, Tsuchida T et al (2002) The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest 121(5):1521–1526CrossRefPubMed Saji H, Nakamura H, Tsuchida T et al (2002) The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest 121(5):1521–1526CrossRefPubMed
17.
Zurück zum Zitat Yamagami T, Nakamura T, Iida S et al (2002) Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest 121(4):1159–1164CrossRefPubMed Yamagami T, Nakamura T, Iida S et al (2002) Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest 121(4):1159–1164CrossRefPubMed
18.
Zurück zum Zitat Kothary N, Lock L, Sze DY et al (2009) Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin Lung Cancer. 10(5):360–363CrossRefPubMed Kothary N, Lock L, Sze DY et al (2009) Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin Lung Cancer. 10(5):360–363CrossRefPubMed
19.
Zurück zum Zitat Hiraki T, Mimura H, Gobara H et al (2009) CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. Chest 136(6):1612–1617CrossRefPubMed Hiraki T, Mimura H, Gobara H et al (2009) CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. Chest 136(6):1612–1617CrossRefPubMed
20.
Zurück zum Zitat Williams A, Tammemagi MC et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369(10):910–919CrossRef Williams A, Tammemagi MC et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369(10):910–919CrossRef
21.
Zurück zum Zitat Vansteenkiste JF, Stroobants SS (2006) PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 1(1):71–73CrossRefPubMed Vansteenkiste JF, Stroobants SS (2006) PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 1(1):71–73CrossRefPubMed
22.
Zurück zum Zitat Reyes N, Onadeko OO et al (2014) Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 192(4):589–593CrossRefPubMed Reyes N, Onadeko OO et al (2014) Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 192(4):589–593CrossRefPubMed
24.
Zurück zum Zitat Zelch JV, Lalli AF, McCormack LJ et al (1973) Aspiration biopsy in diagnosis of pulmonary nodule. Chest 63(2):149–152CrossRefPubMed Zelch JV, Lalli AF, McCormack LJ et al (1973) Aspiration biopsy in diagnosis of pulmonary nodule. Chest 63(2):149–152CrossRefPubMed
25.
Zurück zum Zitat VanSonnenberg E, Casola G, Ho M et al (1988) Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology 167(2):457–461CrossRefPubMed VanSonnenberg E, Casola G, Ho M et al (1988) Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology 167(2):457–461CrossRefPubMed
26.
Zurück zum Zitat Choi SH, Chae EJ et al (2013) Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: analysis of outcomes of 305 procedures from a tertiary referral center. Am J Roentgenol 201(5):964–970CrossRef Choi SH, Chae EJ et al (2013) Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: analysis of outcomes of 305 procedures from a tertiary referral center. Am J Roentgenol 201(5):964–970CrossRef
27.
Zurück zum Zitat Chitkara YK (1997) Evaluation of cultures of percutaneous core needle biopsy specimens in the diagnosis of pulmonary nodules. Am J Clin Pathol 107(2):224–228CrossRefPubMed Chitkara YK (1997) Evaluation of cultures of percutaneous core needle biopsy specimens in the diagnosis of pulmonary nodules. Am J Clin Pathol 107(2):224–228CrossRefPubMed
28.
Zurück zum Zitat Anderson JM, Murchison J, Patel D (2003) CT-guided lung biopsy: factors influencing diagnostic yield and complication rate. Clin Radiol 58(10):791–797CrossRefPubMed Anderson JM, Murchison J, Patel D (2003) CT-guided lung biopsy: factors influencing diagnostic yield and complication rate. Clin Radiol 58(10):791–797CrossRefPubMed
Metadaten
Titel
Complications and Yield of Computed Tomography-Guided Transthoracic Core Needle Biopsy of Lung Nodules at a High-Volume Academic Center in an Endemic Coccidioidomycosis Area
verfasst von
Mickey Sachdeva
Reza Ronaghi
Paul K. Mills
Michael W. Peterson
Publikationsdatum
15.03.2016
Verlag
Springer US
Erschienen in
Lung / Ausgabe 3/2016
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9866-3

Weitere Artikel der Ausgabe 3/2016

Lung 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.